ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Discussion
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Sunil K. Bhudia
Patrick M. McCarthy
Nicholas G. Smedira
Buu-Khanh Lam
Eugene H. Blackstone
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhudia, S. K.
Right arrow Articles by Blackstone, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhudia, S. K.
Right arrow Articles by Blackstone, E. H.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2004;77:1598-1606
© 2004 The Society of Thoracic Surgeons


Original article: cardiovascular

Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings

Sunil K. Bhudia, MDa, Patrick M. McCarthy, MDa*, Nicholas G. Smedira, MDa, Buu-Khanh Lam, MDa, Jeevanantham Rajeswaran, MSb, Eugene H. Blackstone, MDa,b

a Department of Thoracic and Cardiovascular Surgery, Cleveland, Ohio, USA
b Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

Accepted for publication September 22, 2003.

* Address reprint requests to Dr McCarthy, The Cleveland Clinic Foundation, Department of Thoracic and Cardiovascular Surgery, 9500 Euclid Ave, Desk F25, Cleveland, OH 44195, USA
e-mail: mccartp{at}ccf.org

Presented at the Thirty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 31–Feb 2, 2003.


    Abstract
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
BACKGROUND: Complex mitral regurgitation (MR) jets can make repair challenging; edge-to-edge (Alfieri) repair augments the repertoire of repair techniques. Objectives of this study were to demonstrate causes of MR amenable to edge-to-edge repair and to determine safety, obstructive potential, and durability of edge-to-edge repair.

METHODS: From January 1997 to October 2001, 224 patients underwent Alfieri repair. Indications included ischemic cardiomyopathy (n = 143, 64%), myxomatous disease (n = 31, 14%), dilated cardiomyopathy (n = 27, 12%), and hypertrophic obstructive cardiomyopathy (n = 14, 6%). Concomitant ring annuloplasty was performed in 188 patients (84%). Two additional patients had takedown of an Alfieri repair in the operating room for obstruction. Preoperative MR was 4+ in 109 patients (50%) and 3+ in 65 (30%). Postoperative and follow-up mitral gradient and return of MR were assessed using 396 transthoracic echocardiograms and longitudinal analyses.

RESULTS: Hospital mortality was 2% (5 of 224). Mitral valve mean gradient was low (3.7 mm Hg) and nonprogressive (p = 0.7), although peak gradient rose slightly, from mean 8.4 to 10.0 mm Hg (p = 0.01). During the first 3 postoperative months, absence of MR declined to 40%, and prevalence of 3+ MR increased to 14%, then rose slowly thereafter. Fourteen patients—12 within 2 years—underwent mitral valve reoperation, none for stenosis; 7 patients—6 within 2 years—underwent heart transplantation.

CONCLUSIONS: Alfieri mitral repair can be used in a variety of settings with a low risk of creating mitral stenosis. However, in ischemic MR, steadily increasing prevalence of moderately severe and severe regurgitation after edge-to-edge repair suggests other techniques are needed.


    Introduction
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 

This article has been selected for the open discussion forum on the CTSNet Web site: http://www.ctsnet.org/discuss

 

For most patients with mitral regurgitation (MR), valve repair is desirable [1], but may be technically challenging, particularly when complex jets accompany ischemic MR. Alfieri and colleagues [2, 3] introduced a simple edge-to-edge suture approximation of anterior and posterior mitral leaflets as a reproducible and effective technique for restoring valve competence. However, most of their patients had degenerative (myxomatous) disease [24]. In 1996, we began applying the edge-to-edge technique in patients with end-stage heart failure who were undergoing partial left ventriculectomy [5]. We then expanded its use to a wider variety of causes of MR, particularly ischemic cardiomyopathy with complex MR. Objectives of this study were to demonstrate causes of MR amenable to edge-to-edge repair, particularly ischemic cardiomyopathy, and to determine safety, potential for mitral valve obstruction, and durability of edge-to-edge repair.


    Patients and methods
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
Patients
From January 1997 to October 2001, 224 patients underwent edge-to-edge mitral valve repair at The Cleveland Clinic Foundation. Patients who had partial left ventriculectomy (Batista procedure), in whom we first used edge-to-edge repair, were excluded; they have been reported previously [6]. The majority of patients had moderately severe or severe MR by preoperative transthoracic echocardiography (Table 1). Those with no or mild MR preoperatively but who showed evidence of systolic anterior motion or increased MR (>2+) by intraoperative transesophageal echocardiography underwent edge-to-edge repair. Half the patients had severe left ventricular dysfunction, and 61% were in New York Heart Association class III or IV.


View this table:
[in this window]
[in a new window]
 
Table 1. Preoperative Patient Characteristics

 
Two additional patients had what was thought to be mitral stenosis intraoperatively and were successfully treated by takedown of the edge-to-edge approximation while in the operating room. They are not included in the analysis of postoperative mitral valve obstruction or durability of repair.

Operative technique
Exposure of the mitral valve was generally through the left atrium (76%; Table 2). Approach was through the aorta (15%) in patients undergoing myectomy for hypertrophic obstructive cardiomyopathy (HOCM) and in those undergoing aortic valve replacement who had less than 4+ MR and underwent mitral valve repair without annuloplasty. Twenty patients (9%) undergoing left ventricular reconstruction for ischemic cardiomyopathy had stitches placed through the ventriculotomy.


View this table:
[in this window]
[in a new window]
 
Table 2. Operative Details

 
Decision to use an Alfieri repair was made by the surgeon to correct complex MR jets (such as in ischemic or idiopathic cardiomyopathy), to prevent or treat systolic anterior motion in myectomy surgery for HOCM, or to reduce MR in patients undergoing aortic valve surgery (typically in the setting of a calcified mitral annulus in elderly patients). Alfieri repair was also used for a small group of patients who had discrete, localized anterior leaflet flail. In this group, need for complex chordal transfer to a discrete, unsupported anterior leaflet defect was avoided. However, the majority of our patients with myxomatous degeneration were treated with conventional techniques of quadrangular resection, flexible annuloplasty, sliding annuloplasty as needed, and chordal transfer if they had extensive anterior leaflet flail.

Edge-to-edge approximation was accomplished using a figure-of-eight 4-0 polyester suture for most repairs, with the suture placed in the center (89%) of the anterior and posterior leaflets. However, after further experience in ischemic cardiomyopathy patients with complex jets arising near the posteromedial commissure, a more extensive repair using four figure-of-eight sutures was used to close the posteromedial commissure (10%). In 1 patient the anterolateral commissure was closed.

Annuloplasty was performed in the majority of patients (84%), almost exclusively using a flexible partial band that extended from trigone to trigone. Size of annuloplasty ring varied according to disease cause (Table 3). In ischemic or functional MR, small annuloplasty rings were used, the most common size being 26 mm (70%). Larger rings were used in patients with degenerative disease, the most common size being 32 mm. Frequency distribution for ring size was highly biased toward small rings for ischemic cardiomyopathy, but was not biased in patients with degenerative mitral valve disease. No annuloplasty was performed in patients with HOCM.


View this table:
[in this window]
[in a new window]
 
Table 3. Cause and Ring Sizes

 
Mitral valve repair was occasionally performed as an isolated procedure (n = 15), but was generally coupled with another procedure, including coronary artery bypass grafting, left ventricular reconstruction, myectomy, or aortic valve surgery with or without thoracic aorta repair (Table 2).

Assessment of repair
The repair was assessed with intraoperative transesophageal echocardiography. Preoperative and postoperative transthoracic echocardiographic reports were used to assess MR, mitral valve orifice area, transmitral pressure gradients, and left ventricular function. Mitral regurgitation was graded as 0 for no regurgitation, 1+ for mild, 2+ for moderate, 3+ for moderately severe, and 4+ for severe.


    Data analysis
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
General comments
Data analysis addressed the following questions: (1) Does edge-to-edge repair cause mitral valve obstruction? (2) What is the durability of edge-to-edge repair, particularly in patients with ischemic MR? (3) Does position of edge-to-edge repair on the mitral valve influence durability? (4) What are the risk factors for return of higher grades of MR? (5) What is the survival in these patients?

To address the first question, postoperative transthoracic echocardiograms were analyzed for mean and peak transmitral gradients and mitral orifice area. Durability of edge-to-edge repair was assessed by evolution of MR postoperatively. Preoperative and intraoperative risk factors for return of higher grade MR were sought in general, but in particular, durability was compared (1) between patients with and without ischemic MR, and (2) between patients with and without left ventricular reconstruction or ischemic MR. Survival was assessed by time-related analysis.

Data
Values for preoperative, operative, and postoperative variables were retrieved from the prospective computerized Cardiovascular Information Registry. Values for preoperative, operative, and postoperative echocardiogram assessments were retrieved from the echocardiography database. Both databases have been approved for research by the institutional review board. Postoperative and follow-up transthoracic echocardiograms were available in 214 patients with a total of 396 assessments made between 1 day and 4.8 years after repair (median, 3 weeks; quartiles, 6 days and 8 months; Appendix Table 1).

Safety (hospital outcomes)
Hospital morbidity, recorded in the Cardiovascular Information Registry database, included in-hospital death, cerebral vascular accident, perioperative myocardial infarction based on routine creatine kinase MB and electrocardiographic criteria, renal failure (dialysis or creatinine > 2.5 mg/dL), respiratory insufficiency (reintubation or ventilatory support > 48 hours), septicemia or sepsis (by blood cultures), and postoperative bleeding or tamponade requiring reoperation.

Orifice obstruction
Temporal trends of mean transmitral gradient, peak transmitral gradient, mitral valve orifice area, and indexed orifice area (square centimeter per square meter body surface area) after repair were analyzed using longitudinal mixed-model regression for repeated measurements (SAS PROC MIXED) [7]. Mitral valve orifice area measurements were available on only 40 patients, with a total of 49 assessments.


    Durability
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
Longitudinal ordinal logistic regression for repeated measurements (SAS PROC GENMOD) was used to analyze the overall evolution of postoperative MR. This analysis revealed a steep change within the first month after edge-to-edge repair. Thus, risk factors for higher grade of MR were sought separately for echocardiographic assessments made within the first month (early) and those made later.

Because of the limited capability of PROC GENMOD to explore multivariable relationships, we initially screened variables using ordinary multivariable logistic regression and the assumption of independence of observations with liberal entry (p = 0.2) and retention (p = 0.12) criteria. This analysis identified possible candidates for repeated-measurement analysis. These candidates and their transformations of scale were entered simultaneously into the longitudinal model, then eliminated one by one until all variables remaining had a p value of 0.1 or less. Variables analyzed are shown in the Appendix.

Because frequency of occurrence of severe MR (4+) was rare, moderately severe (3+) and severe (4+) MR were combined for the risk factor analysis.

Strategy of analysis was to first identify preoperative risk factors, then to add to these intraoperative factors.

Influence of ischemic cause on durability
As a focused study, patients were stratified into ischemic and nonischemic cardiomyopathy groups, and influence of cause on repair durability was analyzed. Nonischemic group was further stratified into dilated cardiomyopathy and degenerative mitral disease, and durability of repair was compared with the ischemic group. In the later analysis, patients with HOCM and other causes of MR were excluded.

Influence of left ventricular reconstruction procedure in ischemic cause on durability
As another focused study, patients with ischemic cardiomyopathy were stratified by whether or not they had left ventricular reconstruction. For this analysis, 254 assessments of MR were available on 134 patients.

Influence of position of edge-to-edge repair on durability
Patients were stratified by the position of edge-to-edge repair, either central or commissural. For this analysis, 353 assessments for MR were available on 200 patients with central edge-to-edge repair and 43 assessments were available on 24 patients with commissural repair.


    Survival
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
Nonparametric [8] and parametric [9] estimates of survival were performed and the hazard function estimated. (For details, see http://www.clevelandclinic.org/heartcenter/hazard.)


    Results
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
Applicability
Cause of MR in the majority of patients having edge-to-edge mitral repair was ischemic cardiomyopathy (Table 4). However, it was applied to a wide spectrum of patients, including those with degenerative mitral disease, dilated cardiomyopathy, and HOCM (Table 4).


View this table:
[in this window]
[in a new window]
 
Table 4. Cause of Cardiac Disease

 
Safety
Forty-eight patients experienced in-hospital postoperative complications: respiratory insufficiency in 30 (13%), septicemia or sepsis in 17 (8%), renal failure in 8 (4%), postoperative bleeding requiring surgical intervention in 8 (4%), myocardial infarction in 4 (2%), and cerebral vascular accident in 2 (1%).

Obstruction
On postoperative day 1, mean transmitral pressure gradient was 3.7 mm Hg (Table 5). As a function of time, no demonstrable increase occurred (p = 0.7). Similarly, peak transmitral pressure gradient was 8.4 mm Hg (Table 5) immediately after operation, and with time it rose only slightly, although statistically significantly (p = 0.01). Mean mitral valve orifice area on postoperative day 1 was 2.1 cm2; indexed area was 1.16 cm2/m2 and was stable with time (p = 0.4; Table 5).


View this table:
[in this window]
[in a new window]
 
Table 5. Quantification of Mitral Orifice Obstructiona

 
Durability
Mitral regurgitation at predischarge was none (0) in 79% of patients, 1+ in 11%, 2+ in 6%, 3+ in 4%, and 4+ in 1%. Within the first 9 months after repair there was a rapid change in grade (p < 0.0001; Fig 1). Generally, the proportion of patients with no MR declined sharply, but the proportion in grade 1+ changed more slowly (from 11% at day 1 to 20% by 2 years). At 2 years, the proportion of patients with moderate MR (2+) increased to 23%, and the proportion with moderately severe regurgitation (3+) increased to 24%. Few patients had severe (4+) MR. Generally, patients with ischemic cardiomyopathy developed higher MR grades than those with dilated cardiomyopathy (p = 0.02) and degenerative mitral disease (p = 0.002; Fig 2). There was no difference in the evolution of MR between patients with dilated cardiomyopathy and those with degenerative mitral disease (p = 0.1; Fig 2).



View larger version (16K):
[in this window]
[in a new window]
 
Fig 1. Evolution of mitral regurgitation (MR) after edge-to-edge mitral valve repair. Symbols represent grouped data according to percent of observations of grade of mitral regurgitation • = grade 0; {circ} = 1+; {square} = 2+; {Delta} = 3+; {diamond} = 4+. Solid lines indicate predicted mean percentage of patients in each MR grade with time from longitudinal modeling.

 


View larger version (17K):
[in this window]
[in a new window]
 
Fig 2. Patients with mitral regurgitation (MR) grades 3+ or 4+ after edge-to-edge repair in patients with ischemic cardiomyopathy, dilated cardiomyopathy, and degenerative mitral disease. Solid lines indicate predicted mean percentage of patients and dashed lines indicate 68% confidence limits from longitudinal model. • = ischemic; {circ} = dilated; {square} = degenerative.

 
Within the group of patients with ischemic cardiomyopathy, the pattern of MR evolution was similar for those who had left ventricular reconstruction and those who did not (p = 0.8; Fig 3).



View larger version (19K):
[in this window]
[in a new window]
 
Fig 3. Predicted percentage of patients with grade 3+ or 4+ mitral regurgitation (MR) after edge-to-edge repair according to left ventricular reconstruction (solid line and •) or not (solid line and {circ}) among patients with preoperative ischemic mitral regurgitation. Dashed lines(broad = left ventricular reconstruction; narrow = non–left ventricular reconstruction) show 68% confidence limits.

 
The pattern of MR evolution in patients who had central edge-to-edge repair was similar to that of patients who had commissural edge-to-edge repair (p = 0.4). Only 24 patients had commissural repair, with 43 echocardiograms available.

Two sequential models (preoperative variables only and preoperative plus intraoperative factors) for return of higher grades of MR within the first month after operation identified history of previous cardiac operation and earlier date of operation as risk factors (Table 6). Two sequential models of late (after 1 month) return of higher grades of MR identified ischemic cardiomyopathy, higher preoperative MR, history of myocardial infarction, and nonuse of an annuloplasty ring as risk factors (Table 6).


View this table:
[in this window]
[in a new window]
 
Table 6. Risk Factors for Return of Higher Grade of Mitral Regurgitation

 
Reoperation
To date, 21 patients are known to have undergone reoperation, with mitral valve replacement in 14 (Table 7) and heart transplantation in 7. Most had MR associated with ischemic annular dilatation. Breakdown of the edge-to-edge repair led to reoperation in only 1 patient (patient 8).


View this table:
[in this window]
[in a new window]
 
Table 7. Reoperation After Edge-to-Edge Repair of Mitral Valve Regurgitation

 
Of patients who underwent heart transplantation, 3 had ischemic cardiomyopathy and 4 had dilated cardiomyopathy. All had return of severe MR, but none had disruption of the edge-to-edge repair.

Survival
Survival was 65% at 5 years (Fig 4). Thirty-day operative mortality for the 224 patients was 1%, and hospital mortality was 2% (5 patients). Hospital mortality for ischemic cardiomyopathy patients was 2% (3 patients).



View larger version (12K):
[in this window]
[in a new window]
 
Fig 4. Freedom from death. The solid line shows predicted curve with 68% confidence limits in dashed line. Numbers in parentheses show patients at risk at 1, 3, and 4.5 years.

 

    Comment
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
In general, mitral valve repair is superior to replacement for MR, with lower operative mortality, improved late survival, reduced risk of endocarditis, fewer thromboembolic complications, and better preservation of ventricular function [1]. Alfieri and colleagues [2] report good results in their series of patients undergoing mitral valve repair, but most patients had degenerative (myxomatous) disease. We have been generally satisfied with early and late results of Carpentier-inspired techniques for myxomatous mitral valve repair; however, we found the Alfieri repair to be a useful and simple option for patients with a small anterior leaflet flail, and it appears to be durable in our series as well as in that of Alfieri and associates [2]. The more vexing problem has been repair of complex MR, especially in patients with ischemic cardiomyopathy or functional MR secondary to idiopathic dilated cardiomyopathy [6, 10]. In a previous report, we found a subset of patients with advanced ischemic cardiomyopathy, complex jets, and reduced ventricular function who showed no benefit from mitral valve repair versus replacement [11]. Their characteristics, including left ventricular dysfunction, New York Heart Association functional class, other cardiac comorbidity, and noncardiac comorbidity, are similar to those of the ischemic cardiomyopathy patients reported in this study, for whom we are seeking an effective and durable mitral repair technique. Because the goal of annuloplasty using an undersized ring is to increase the zone of coaptation [12], suturing the leaflets together seemed reasonable.

Although our initial results using edge-to-edge approximation in addition to a small flexible band were satisfactory, 24% of patients had recurrence of 3+ MR within 2 years. This leaves them at risk for further volume overload with an impaired left ventricle and return of heart failure symptoms.

There are several reasons why repair may have failed. First, at reoperation the most common finding was progressive annular dilatation with a well-seated ring and intact edge-to-edge repair. A recent report indicates that the trigone to trigone area is not a rigid fixed structure, as was previously thought, and dilatation occurs in this area [13, 14]. Second, left ventricular remodeling in a failing heart can be progressive. However, we do not have three-dimensional studies to determine whether the ventricles were in fact increasing in size and volume, leading to further displacement of the papillary muscles with increased tethering and subsequent reduction in the zone of coaptation. Third, Calafiore and coworkers [15] have reported that some patients have such extensive tethering, as determined by displacement of the leaflets into the ventricle, that this cannot be overcome with annuloplasty. Instead, they suggest chord-sparing mitral valve replacement. We did not determine from echocardiography whether our patients who developed recurrent MR had this degree of tethering preoperatively. Fourth, some authors claim that patients with ischemic MR treated with a flexible band have a more-rapid return of regurgitation than those treated with a complete remodeling ring [16]. Others suggest not only that a remodeling ring is necessary, but that a rigid one that fixes the annulus more effectively in place closes the septal lateral dimension and does not allow late dilatation [17]. Although our results with a flexible band have been excellent for patients with myxomatous disease [18], this may not be the best choice for those with ischemic or idiopathic cardiomyopathy.

The type of annuloplasty ring and the underlying pathologic process, not disruption of the edge-to-edge approximation, most likely led to recurrence of MR. Disruption was identified in only 1 patient, in whom the stitch had pulled through the leaflet tissue. It is possible that disruption had occurred in others, but it was difficult to appreciate by transthoracic echocardiography.

As our clinical experience with patients with ischemic cardiomyopathy and ventricular reconstructive surgery for ischemic cardiomyopathy increased, we evolved our technique so that Alfieri repair is less frequently used. Currently, we use a 24-mm Physio annuloplasty ring (the smallest available) or a 26-mm classic Carpentier ring (which is more rigid). We do not add an edge-to-edge approximation with these small remodeling rings because of anecdotal reports that such a combination may create mitral stenosis. Although our results have not been analyzed with this strategy, our impression is that residual MR is less than with the flexible band and Alfieri repair, but it is not eliminated. This strategy will be studied in a later report. Also, occasionally we use chord-sparing mitral valve replacement for patients with severely enlarged ventricles and extensive tethering of valve leaflets, as described by Calafiore and associates [15].

Interestingly, patients with ischemic MR were far more likely to redevelop 3+ or 4+ MR than those with dilated cardiomyopathy or, as in the series of Alfieri and colleagues [2], patients with myxomatous disease. Ischemic cardiomyopathy typically is accompanied by complex MR with eccentric jets and tethering or restriction at the medial commissure with annular dilatation. Some patients also have a second jet originating at the lateral commissure [19]. On the other hand, dilated cardiomyopathy has a more symmetric tethering and annular dilatation that may respond more favorably to central edge-to-edge placement. We were not able to determine an advantage to closure of the medial commissure over central edge-to-edge approximation in ischemic cardiomyopathy, but this may be in part related to the small number of patients and the four other possible causes of recurrence previously noted in this paper.

We also report on the use of the edge-to-edge technique for patients with HOCM. The Alfieri repair should lessen the likelihood of systolic anterior motion occasionally seen in HOCM patients after myectomy. However, elimination of systolic anterior motion does not always occur. The stitch is placed centrally, so the lateral portion of the anterior leaflet still can be displaced. Two patients with HOCM who required reoperation had residual gradients associated with myectomy, not failure of edge-to-edge approximation per se.

Apart from the 2 patients who had edge-to-edge approximation taken down because of intraoperative mitral stenosis, we found that once patients left the operating room, there was no evidence of mitral stenosis in the early term or midterm.

In conclusion, like Alfieri and colleagues [2] and Maisano and associates [3], we found good early term and midterm results of edge-to-edge approximation in selected patients with myxomatous mitral valve disease. Creation of mitral stenosis was rare and did not appear to increase with time. Use of a small flexible band with Alfieri repair for patients with ischemic or idiopathic dilated cardiomyopathy had good short-term results but unacceptable late recurrence of 3+ MR. Other techniques and prostheses to treat this complex form of regurgitation are needed.


    Discussion
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
DR WADE L. KNIGHT (Temple, TX): At the European meeting in Monte Carlo in September, Dr Cosgrove was the moderator for a panel that included Dr Alfieri, and Dr Alfieri made a very nice presentation. But at that panel meeting, Dr Cosgrove had little or no enthusiasm for the edge-to-edge repair. So I am curious as to whether you have some intrainstitutional controversy?

DR SARA J. SHUMWAY (Minneapolis, MN): If you cannot answer that question for political reasons, we would understand.

DR BHUDIA: Not all of The Cleveland Clinic Foundation surgeons have used the edge-to-edge repair.

DR SHUMWAY: Were the 16% of patients who did not get a ring annuloplasty more prone to developing late mitral regurgitation, and what was the time interval?

DR BHUDIA: Of the 16 patients who did not have the annuloplasty ring—usually ischemic mitral regurgitation (MR) patients who had left ventricular reconstruction surgery—the time range of increasing MR was anywhere from 1 month to 2 years.

DR STEVEN F. BOLLING (Ann Arbor, MI): You state now that your policy for these patients with ischemic or myopathic MR is to put a very small ring in. Was that your policy in this series?

Was there a difference in ring size between the patients who had recurrent MR and nonrecurrent MR? One can imagine a scenario of a small ring in place, and the Alfieri stitch continues to do its good work in a small ring, whereas in a large ring it is allowed to pull apart and deformation occurs. So could you tell us the difference between ring size in the patients who had MR and did not have MR?

DR BHUDIA: The majority of the patients with ischemic MR had 24 or 26 ring size; in fact, that was about 80% of the patients. Despite that, we saw a high number of patients who experienced return of high-grade MR with time.

DR CRAIG R. SMITH (New York, NY): It would help me to understand exactly when you choose edge-to-edge repair. Was it usually applied when you put in a ring and it was not perfect, so you added an edge-to-edge stitch? Or did you put in an edge-to-edge stitch and reinforce it with a ring, or a little bit of both? I imagine the first scenario is the most common, and it would support your hypothesis.

DR BHUDIA: It is the first scenario. We put the ring in first, and then if there was residual regurgitation, we used the Alfieri stitch.

DR HUMBERTO R. RAVELO (Long Beach, CA): During the earlier Tech Conference portion of the STS meeting, a question was posed to Dr Alfieri regarding the potential hemodynamic consequences of his "edge-to-edge" mitral valve repair. I am not certain this question was clearly answered, and I would like to bring this issue up again.

It was mentioned that, according to fluid hemodynamic principles, [Poiseuille's Law: F = (difference in Pressure)({pi})(the fourth power of the Radius) / (8)(Viscosity)(Length)], the dependence of flow through an orifice on the fourth power of its radius leads to a major change in flow when that radius is altered. Accordingly, if all other variables remain equal, a decrease in the radius of the mitral annulus by 1/2 after an "edge-to-edge" repair should decrease the additive flow through the two newly created smaller orifices to 1/8 of the original flow. Based on this reasoning, could the "edge-to-edge" repair clinically induce some degree of hemodynamic mitral stenosis?

DR BHUDIA: We looked at that with the mean pressure gradient and the peak transmitral pressure gradient. With the mean pressure gradient, we saw that with time it did not change. Although the peak pressure gradient was statistically significantly higher during 2 years, we did not find that it was clinically important. Also, looking at the orifice area, it was greater than 2 cm2 in most patients for whom we had a measurement, and with time it did not change. With all these echocardiographic variables, we did not find any clinically important mitral stenosis.

DR ALVAN W. ATKINSON (Raleigh, NC): One thought is that probably your studies of mitral valve gradients were done at rest. And that is one of our saving graces, I think, in doing some of these repairs, whether we narrow the annulus with a small ring, that we have elderly patients with limited cardiac clinical ability anyway. But did you do any functional studies at high rates of cardiac output?

DR BHUDIA: No, we did not do any stress echocardiographic studies on these patients.


    Appendix. Variables Used in the Analysis
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
Preoperative
Demography
Sex, age, weight, height, body surface area, body mass

Symptoms
New York Heart Association functional class

Ventricular function
Ejection fraction, left and right ventricular function, left ventricular internal diameter in systole and diastole

Pathology
Mitral regurgitation, aortic regurgitation, aortic valve stenosis, tricuspid regurgitation, pulmonary regurgitation

Cause
Ischemic cardiomyopathy, dilated cardiomyopathy, degenerative valvar disease, hypertrophic obstructive cardiomyopathy, endocarditis, functional mitral regurgitation

Cardiac Comorbidity
History of myocardial infarction, electrocardiographic evidence of myocardial infarction, atrial fibrillation, complete heart block, ventricular arrhythmia, history of cardiac surgery, emergency cardiac surgery, number of cardiac surgeries, coronary artery disease by coronary artery territory (left main trunk, left anterior descending artery, left circumflex artery, right coronary artery)

Noncardiac comorbidity
Insulin-dependent diabetes, non–insulin-dependent diabetes, treated diabetes, hypertension, history of peripheral vascular disease, presence of carotid disease, presence of chronic obstructive pulmonary disease, renal disease, history of smoking, creatinine, blood urea nitrogen, bilirubin

Experience
Date of surgery

Intraoperative
Procedure
Internal thoracic artery grafts used, concomitant procedures (coronary artery bypass grafting, left ventricular reconstruction, aortic valve replacement), approach to mitral valve (left atrium, left ventricle, or aorta), annuloplasty ring, annuloplasty ring size.

Support
Ischemic time, perfusion time


    Appendix Table 1
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 
Distribution of Mitral Regurgitation Assessment With Time

Time from Operation to Echocardiogram


Frequency (%)


Cumulative Frequency (%)


1 to 7 days 37 37
8 to 14 days 11 48
15 days to 1 mo 5 53
1 to 2 mo 7 60
2 to 4 mo 7 67
4 to 6 mo 4 71
6 mo to 1 y 10 81
1 to 1.5 y 6 87
1.5 to 2 y 6 93
More than 2 y

7

100


    References
 Top
 Abstract
 Introduction
 Patients and methods
 Data analysis
 Durability
 Survival
 Results
 Comment
 Discussion
 Appendix. Variables Used in...
 Appendix Table 1
 References
 

  1. Yun K.L., Miller D.C. Mitral valve repair versus replacement. Cardiol Clin 1991;9:315-327.[Medline]
  2. Alfieri O., Maisano F., De Bonis M., et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-681.[Abstract/Free Full Text]
  3. Maisano F., Torracca L., Oppizzi M., et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998;13:240-246.
  4. Maisano F., Schreuder J.J., Oppizzi M., Fiorani B., Fino C., Alfieri O. The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique. Eur J Cardiothorac Surg 2000;17:201-205.[Abstract/Free Full Text]
  5. Franco-Cereceda A., McCarthy P.M., Blackstone E.H., et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation?. J Thorac Cardiovasc Surg 2001;121:879-893.[Abstract/Free Full Text]
  6. McCarthy P.M., Starling R.C., Wong J., et al. Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 1997;114:755-765.[Abstract/Free Full Text]
  7. Diggle P.J., Liang K.Y., Zeger S.L. Analysis of longitudinal data. . New York: Oxford University Press, 1994.
  8. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
  9. Blackstone E.H., Naftel D.C., Turner M.E., Jr The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81:615-624.
  10. Tahta S.A., Oury J.H., Maxwell J.M., Hiro S.P., Duran C.M. Outcome after mitral valve repair for functional ischemic mitral regurgitation. J Heart Valve Dis 2002;11:11-19.[Medline]
  11. Gillinov A.M., Wierup P.N., Blackstone E.H., et al. Is repair preferable to replacement for ischemic mitral regurgitation?. J Thorac Cardiovasc Surg 2001;122:1125-1141.[Abstract/Free Full Text]
  12. Bolling S.F. Mitral reconstruction in cardiomyopathy. J Heart Valve Dis 2002;11(Suppl 1):S26-31.
  13. Hueb A.C., Jatene F.B., Moreira L.F., Pomerantzeff P.M., Kallas E., De Oliveira S.A. Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc Surg 2002;124:1216-1224.[Abstract/Free Full Text]
  14. McCarthy P.M. Does the intertrigonal distance dilate? Never say never. J Thorac Cardiovasc Surg 2002;124:1078-1079.[Free Full Text]
  15. Calafiore A.M., Gallina S., Di Mauro M., et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement?. Ann Thorac Surg 2001;71:1146-1153.[Abstract/Free Full Text]
  16. Aklog L, Soltesz EG, Filsoufi F, et al. The impact of residual mitral regurgitation on survival after CABG and annuloplasty for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2003. In press
  17. Miller D.C. Ischemic mitral regurgitation redux—to repair or to replace?. J Thorac Cardiovasc Surg 2001;122:1059-1062.[Free Full Text]
  18. Gillinov A.M., Cosgrove D.M., Blackstone E.H., et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116:734-743.[Abstract/Free Full Text]
  19. Kwan J., Shiota T., Agler D.A., et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003;107:1135-1140.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
F. Langer, T. Kunihara, K. Hell, R. Schramm, K. I. Schmidt, D. Aicher, M. Kindermann, and H.-J. Schafers
RING+STRING: Successful Repair Technique for Ischemic Mitral Regurgitation With Severe Leaflet Tethering
Circulation, September 15, 2009; 120(11_suppl_1): S85 - S91.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Feldman, S. Kar, M. Rinaldi, P. Fail, J. Hermiller, R. Smalling, P. L. Whitlow, W. Gray, R. Low, H. C. Herrmann, et al.
Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) Cohort.
J. Am. Coll. Cardiol., August 18, 2009; 54(8): 686 - 694.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
J.-B. Masson and J. G. Webb
Percutaneous Treatment of Mitral Regurgitation
Circ Cardiovasc Interv, April 1, 2009; 2(2): 140 - 146.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
E. Donal, C. De Place, G. Kervio, F. Bauer, R. Gervais, C. Leclercq, P. Mabo, and J.-C. Daubert
Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony
Eur J Echocardiogr, January 1, 2009; 10(1): 133 - 138.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. K. Balaram, L. Tyrie, M. V. Sherrid, J. Afthinos, Z. Hillel, G. Winson, and D. G. Swistel
Resection-Plication-Release for Hypertrophic Cardiomyopathy: Clinical and Echocardiographic Follow-Up
Ann. Thorac. Surg., November 1, 2008; 86(5): 1539 - 1545.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Hasegawa, Y. Araki, A. Usui, J. Yokote, S. Saito, H. Oshima, and Y. Ueda
Mitral valve motion after performing an edge-to-edge repair in an isolated swine heart
J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 590 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P.M. McCarthy, E.C. McGee, V.H. Rigolin, Q. Zhao, H. Subacius, A.L. Huskin, S. Underwood, B.J. Kane, I. Mikati, G. Gang, et al.
Initial clinical experience with Myxo-ETlogix mitral valve repair ring
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 73 - 81.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. K. Rosengart, T. Feldman, M. A. Borger, T. A. Vassiliades Jr, A. M. Gillinov, K. J. Hoercher, A. Vahanian, R. O. Bonow, and W. O'Neill
Percutaneous and Minimally Invasive Valve Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group
Circulation, April 1, 2008; 117(13): 1750 - 1767.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow
Evolving Concepts and Technologies in Mitral Valve Repair
Circulation, February 19, 2008; 117(7): 963 - 974.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. J. Mack
Percutaneous treatment of mitral regurgitation: so near, yet so far!
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 237 - 239.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
F. Y. Chen and L. H. Cohn
Mitral Valve Repair
Card. Surg. Adult, January 1, 2008; 3(2008): 1013 - 1030.
[Full Text]


Home page
Card Surg AdultHome page
M. J. Davidson and D. S. Baim
Percutaneous Catheter-Based Mitral Valve Repair
Card. Surg. Adult, January 1, 2008; 3(2008): 1101 - 1108.
[Full Text]


Home page
CirculationHome page
T. Feldman and M. B. Leon
Prospects for Percutaneous Valve Therapies
Circulation, December 11, 2007; 116(24): 2866 - 2877.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. R. Croft, J. H. Jimenez, R. C. Gorman, J. H. Gorman III, and A. P. Yoganathan
Efficacy of the Edge-to-Edge Repair in the Setting of a Dilated Ventricle: An In Vitro Study
Ann. Thorac. Surg., November 1, 2007; 84(5): 1578 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. O. Bader, O. M. Lattouf, and R. M. Sniecinski
Transesophageal Echocardiography of the Edge-to-Edge Technique of Mitral Valve Repair
Anesth. Analg., November 1, 2007; 105(5): 1231 - 1232.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
U. Sartipy, A. Albage, E. Mattsson, and D. Lindblom
Edge-to-Edge Mitral Repair Without Annuloplasty in Combination With Surgical Ventricular Restoration
Ann. Thorac. Surg., April 1, 2007; 83(4): 1303 - 1309.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
M. Basaran, O. Selimoglu, T. Yildirim, and N. Temucin Ogus
Use of Alfieri stitch technique in a patient with hypertrophic obstructive cardiomyopathy
Interactive CardioVascular and Thoracic Surgery, December 1, 2006; 5(6): 738 - 739.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Kuduvalli, S. V. Ghotkar, A. D. Grayson, and B. M. Fabri
Edge-to-Edge Technique for Mitral Valve Repair: Medium-Term Results With Echocardiographic Follow-Up.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1356 - 1361.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. H. Jimenez, J. Forbess, L. R. Croft, L. Small, Z. He, and A. P. Yoganathan
Effects of annular size, transmitral pressure, and mitral flow rate on the edge-to-edge repair: an in vitro study.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1362 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y.-Q. Lai, X. Meng, T. Bai, C. Zhang, Y. Luo, and Z.-G. Zhang
Edge-to-Edge Tricuspid Valve Repair: An Adjuvant Technique for Residual Tricuspid Regurgitation
Ann. Thorac. Surg., June 1, 2006; 81(6): 2179 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J.-M. Frapier, C. Sportouch, V. Rauzy, P. Rouviere, S. Cade, R. G. Demaria, J.-M. Davy, and B. Albat
Mitral valve repair by Alfieri's technique does not limit exercise tolerance more than Carpentier's correction.
Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 1020 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. R. Brinster, D. Unic, M. N. D'Ambra, N. Nathan, and L. H. Cohn
Midterm Results of the Edge-to-Edge Technique for Complex Mitral Valve Repair.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1612 - 1617.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Langer, F. Rodriguez, A. Cheng, S. Ortiz, T. C. Nguyen, M. K. Zasio, D. Liang, G. T. Daughters, N. B. Ingels, and D. C. Miller
Posterior mitral leaflet extension: An adjunctive repair option for ischemic mitral regurgitation?
J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 868 - 877.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Pitfalls and limitations in measuring and interpreting the outcomes of mitral valve repair.
J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 523 - 529.



Home page
Ann. Thorac. Surg.Home page
M. A. Borger, A. Alam, P. M. Murphy, T. Doenst, and T. E. David
Chronic Ischemic Mitral Regurgitation: Repair, Replace or Rethink?
Ann. Thorac. Surg., March 1, 2006; 81(3): 1153 - 1161.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Shemin
Percutaneous Valve Intervention: A Surgeon's Perspective
Circulation, February 14, 2006; 113(6): 774 - 775.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Oc, G. Doukas, C. Alexiou, B. Oc, L. Hadjinikolaou, A. W. Sosnowski, and T. J. Spyt
Edge-to-Edge Repair With Mitral Annuloplasty for Barlow's Disease
Ann. Thorac. Surg., October 1, 2005; 80(4): 1315 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. J. Grande-Allen, J. E. Barber, K. M. Klatka, P. L. Houghtaling, I. Vesely, C. S. Moravec, and P. M. McCarthy
Mitral valve stiffening in end-stage heart failure: Evidence of an organic contribution to functional mitral regurgitation
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 783 - 790.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Langer, F. Rodriguez, S. Ortiz, A. Cheng, T. C. Nguyen, M. K. Zasio, D. Liang, G. T. Daughters, N. B. Ingels, and D. C. Miller
Subvalvular Repair: The Key to Repairing Ischemic Mitral Regurgitation?
Circulation, August 30, 2005; 112(9_suppl): I-383 - I-389.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. De Bonis, E. Lapenna, G. La Canna, E. Ficarra, M. Pagliaro, L. Torracca, F. Maisano, and O. Alfieri
Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy: Role of the "Edge-to-Edge" Technique
Circulation, August 30, 2005; 112(9_suppl): I-402 - I-408.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Levine and E. Schwammenthal
Ischemic Mitral Regurgitation on the Threshold of a Solution: From Paradoxes to Unifying Concepts
Circulation, August 2, 2005; 112(5): 745 - 758.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Jones
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1517 - 1528.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. A. Vassiliades Jr, P. C. Block, L. H. Cohn, D. H. Adams, J. S. Borer, T. Feldman, D. R. Holmes, W. K. Laskey, B. W. Lytle, M. J. Mack, et al.
The Clinical Development of Percutaneous Heart Valve Technology: A Position Statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA)
J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1554 - 1560.
[Full Text] [PDF]


Home page
CirculationHome page
P. C. Block
Percutaneous Mitral Valve Repair: Are They Changing the Guard?
Circulation, May 3, 2005; 111(17): 2154 - 2156.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
American College of Cardiology Foundation (ACCF) a, T. A. Vassiliades Jr, P. C. Block, L. H. Cohn, D. H. Adams, J. S. Borer, T. Feldman, D. R. Holmes, W. K. Laskey, B. W. Lytle, et al.
The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI)
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 970 - 976.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. A. Vassiliades Jr, P. C. Block, L. H. Cohn, D. H. Adams, J. S. Borer, T. Feldman, D. R. Holmes, W. K. Laskey, B. W. Lytle, M. J. Mack, et al.
The Clinical Development of Percutaneous Heart Valve Technology: A Position Statement of The Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI)
Ann. Thorac. Surg., May 1, 2005; 79(5): 1812 - 1818.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
O. Alfieri and F. Maisano
INVITED COMMENTARY
Ann. Thorac. Surg., February 1, 2005; 79(2): 474 - 474.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The year in valvular heart disease
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 111 - 122.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Discussion
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Sunil K. Bhudia
Patrick M. McCarthy
Nicholas G. Smedira
Buu-Khanh Lam
Eugene H. Blackstone
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhudia, S. K.
Right arrow Articles by Blackstone, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhudia, S. K.
Right arrow Articles by Blackstone, E. H.
Related Collections
Right arrow Valve disease


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS